New York, NY, United States of America

Thomas Chippas

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Chippas: Innovator in Blockchain Financial Instruments

Introduction

Thomas Chippas is a notable inventor based in New York, NY (US). He has made significant contributions to the field of financial technology, particularly in the realm of blockchain-integrated systems. His innovative approach has led to the development of a unique trading system that leverages the complexities of cryptocurrency.

Latest Patents

Chippas holds a patent for an "Electronic trading and settlement system for blockchain-integrated cryptographic difficulty-based financial instruments." This financial instrument trading system allows for the establishment and trading of cryptographic difficulty-based financial instruments using the physical delivery of the underlying cryptocurrency. The system is designed to calculate daily variation margins in the valuation of the financial instrument and provides for the physical delivery of the underlying cryptocurrency to satisfy the variation margin.

Career Highlights

Chippas is currently associated with Eris Digital Holdings, LLC, where he continues to innovate in the financial technology sector. His work focuses on creating systems that enhance the trading experience and improve the efficiency of cryptocurrency transactions.

Collaborations

Some of his notable coworkers include Matthew Norbert Trudeau and Joseph McGlawn, who contribute to the collaborative environment at Eris Digital Holdings, LLC.

Conclusion

Thomas Chippas is a pioneering inventor whose work in blockchain financial instruments is shaping the future of trading systems. His innovative patent reflects a deep understanding of cryptocurrency dynamics and positions him as a key player in the financial technology landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…